Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Here's Why Horizon Therapeutics (HZNP) is a Strong Growth Stock
11:30am, Friday, 17'th Mar 2023
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Stocks Gurus Are Trying Their Luck With for St. Patrick's Day
02:57pm, Thursday, 16'th Mar 2023
Ahead of St. Patrick's Day, when everyone is Irish for a day, investors may be interested in trying their luck with companies headquartered on the Emerald Isle.
Horizon's (HZNP) Q4 Earnings and Revenues Surpass Estimates
09:47am, Thursday, 02'nd Mar 2023
Horizon Therapeutics (HZNP) reports better-than-expected fourth-quarter 2022 results as it beats the Zacks Consensus Estimate for both revenues and earnings.
Horizon Therapeutics (HZNP) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
05:16am, Thursday, 02'nd Mar 2023
While the top- and bottom-line numbers for Horizon Therapeutics (HZNP) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key m
Horizon Therapeutics (HZNP) Q4 Earnings and Revenues Top Estimates
09:47am, Wednesday, 01'st Mar 2023
Horizon Therapeutics (HZNP) delivered earnings and revenue surprises of 11.01% and 1.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
How Are Biotech ETFs Reacting to Q4 Earnings Releases?
03:48pm, Tuesday, 21'st Feb 2023
The latest earnings from some of the big biotech players came in at mixed this reporting season.
Why Billionaires Paul Tudor Jones and George Soros Bought Up Horizon (HZNP) Stock
11:37am, Wednesday, 15'th Feb 2023
Two billionaires –Paul Tudor Jones and George Soros — acquired shares of Horizon Therapeutics (NASDAQ: HZNP ) stock, a drugmaker, last quarter. On Dec. 12, Horizon agreed to be acquired by a giant
Amgen plans mega bond deal to help fund $28 billion Horizon Therapeutics acquisition
02:38pm, Tuesday, 14'th Feb 2023
Biotechnology giant Amgen Inc. began talks with investors on Tuesday about a potential jumbo bond deal to help finance its roughly $28 billion acquisition of Dublin-based Horizon Therapeutics, accordi
Horizon (HZNP) Dazodalibep Meets Goal in Sjogren's Syndrome Study
03:03pm, Thursday, 19'th Jan 2023
Horizon Therapeutics (HZNP) announces that a phase II Sjogren's syndrome study of its candidate, dazodalibep, meets the primary endpoint for the second population.
HZNP vs. RGEN: Which Stock Is the Better Value Option?
12:48pm, Thursday, 12'th Jan 2023
HZNP vs. RGEN: Which Stock Is the Better Value Option?
Ranking The 10 Largest Biotechs By Pipeline
12:34pm, Wednesday, 11'th Jan 2023
The pipeline is the heart of all drug discovery companies, leading to all growth in the future. As such, understanding the relative strength of a pipeline by comparing to peers can lead to investment
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
06:26pm, Friday, 06'th Jan 2023
Not every stock went down in 2022. Shares in some the biggest pharmaceutical companies rose in price.
These Are The Top 10 Holdings Of John Paulson
10:54pm, Tuesday, 03'rd Jan 2023
John Paulson is the founder, president and portfolio manager at Paulson & Co.
These Are The 5 Best Dow Jones Stocks For 2022
01:07pm, Thursday, 29'th Dec 2022
Biotechs, insurers and heavy equipment were among the best Dow Jones stocks for 2022. An oil stock led, even though oil prices declined.
Horizon Therapeutics: A Strong Stock to End 2022
11:00am, Saturday, 24'th Dec 2022
If you need an "end-of-the-year stock, here are three reasons why Horizon Therapeutics could be an outstanding stock to consider.
